CDK2 and non-small cell lung carcinoma: Such transcriptional and post-transcriptional repression was observed in different NSCLC, prostate and breast cancer cell lines and we propose that this potentiates and synergizes the Roscovitine-mediated CDK2 inhibition thus resulting in a significant decrease of cellular NHEJ ability.